^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

PTK7-targeted antibody-drug conjugate

Phase 1b
AbbVie
Active, not recruiting
Last update posted :
06/27/2023
Initiation :
02/13/2020
Primary completion :
02/13/2024
Completion :
02/13/2024
PTK7
|
PTK7 expression
|
cofetuzumab pelidotin (ABBV-647)